Comparison of Two Types of Radiofrequency Treatment for Trigeminal Neuralgia
TN-RFA-MEU25
Comparison of Gasserian Ganglion Conventional Radiofrequency and Peripheral Pulsed Radiofrequency in Trigeminal Neuralgia
1 other identifier
interventional
60
1 country
1
Brief Summary
Trigeminal neuralgia (TN) is a chronic pain condition that affects the face, often causing sharp, electric shock-like pain in areas served by the trigeminal nerve. When medications are no longer effective, interventional procedures such as radiofrequency ablation (RFA) may be used. This retrospective study compares two different RFA techniques in patients with classical TN: (1) conventional thermal RFA applied to the Gasserian ganglion, and (2) pulsed RFA applied peripherally to the nerve branches. The purpose of the study is to evaluate pain relief, patient satisfaction, and complication rates between these two commonly used techniques. A total of 60 patients aged 55-80 years, who were treated at the Mersin University Pain Clinic between January 2015 and June 2025, were included. The study uses clinical records and follow-up data to assess outcomes at 6 months post-procedure. This study aims to provide clinicians with more evidence to guide the selection of safer and more effective treatments for trigeminal neuralgia, with the goal of improving patients' quality of life and reducing treatment-related side effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2025
CompletedFirst Posted
Study publicly available on registry
June 10, 2025
CompletedStudy Start
First participant enrolled
June 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedJune 10, 2025
June 1, 2025
16 days
June 2, 2025
June 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Intensity Reduction
Change in pain intensity score measured on the Numerical Rating Scale (NRS) from baseline to 6 months post-procedure.
Baseline and 6 months after intervention
Secondary Outcomes (1)
Patient Satisfaction Score
6 months post-procedure
Study Arms (2)
Conventional Radiofrequency
ACTIVE COMPARATORPatients in this group received conventional thermal radiofrequency (RFA) treatment targeting the Gasserian ganglion. The procedure was performed under fluoroscopic guidance using standard techniques. Lesioning was applied at 70-75°C for 60-90 seconds after correct positioning was confirmed with sensory and motor stimulation.
Peripheral Pulsed Radiofrequency
EXPERIMENTALPatients in this group received pulsed radiofrequency (PRF) applied peripherally to the affected branch of the trigeminal nerve (V1, V2, or V3), depending on the pain distribution. The procedure was performed under fluoroscopic guidance. PRF was applied at 42°C for two cycles of 120 seconds.
Interventions
Conventional RFA was performed at the Gasserian ganglion under fluoroscopic guidance with thermal lesioning at 70-75°C for up to 90 seconds. Sensory and motor stimulation were used to verify needle placement.
PRF was applied to the peripheral branch of the trigeminal nerve at 42°C for two cycles of 120 seconds using fluoroscopic guidance. This technique was preferred in our clinic to avoid thermal complications such as hypoesthesia or motor dysfunction.
Eligibility Criteria
You may qualify if:
- Patients aged between 55 and 80 years with a diagnosis of classical trigeminal neuralgia according to the International Classification of Headache Disorders, 3rd edition (ICHD-3). Patients must have experienced pain refractory to medical management for at least 6 months and have complete clinical and procedural records available, including follow-up data for a minimum of 6 months.
You may not qualify if:
- Patients with secondary trigeminal neuralgia due to structural causes such as multiple sclerosis or tumors, those with a history of prior craniofacial surgery or neuroablative procedures, patients lacking sufficient follow-up data, and those with contraindications to sedation or with uncontrolled systemic comorbidities are excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mesut Bakırlead
Study Sites (1)
Mersin University Faculty of Medicine, Department of Algology
Mersin, Mersin, 33110, Turkey (Türkiye)
Related Publications (2)
Chua NH, Vissers KC, Sluijter ME. Pulsed radiofrequency treatment in interventional pain management: mechanisms and potential indications-a review. Acta Neurochir (Wien). 2011 Apr;153(4):763-71. doi: 10.1007/s00701-010-0881-5. Epub 2010 Nov 30.
PMID: 21116663BACKGROUNDBakir M, Turkyilmaz GG, Teker N, Yavuz K, Ilcan B, Rumeli S. Comparison of Gasserian ganglion conventional radiofrequency ablation and peripheral nerve pulsed radiofrequency in trigeminal neuralgia: a retrospective cohort study. J Oral Facial Pain Headache. 2026 Jan;40(1):119-126. doi: 10.22514/jofph.2025.063. Epub 2026 Jan 12.
PMID: 41607329DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mesut Bakır, Assoc. Prof
Mersin University Faculty of Medicine, Pain Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- Participants and investigators know which intervention is being received.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assoc. Prof. Dr. Mesut Bakır, Mersin University, Department of Algology
Study Record Dates
First Submitted
June 2, 2025
First Posted
June 10, 2025
Study Start
June 15, 2025
Primary Completion
July 1, 2025
Study Completion
July 30, 2025
Last Updated
June 10, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- De-identified individual participant data and selected supporting documents will be available upon request beginning 6 months after publication. Data will remain available for 5 years.
- Access Criteria
- Researchers affiliated with academic institutions may request access to anonymized individual participant data and related documents for non-commercial research. Requests must include a brief study proposal and will be reviewed by the principal investigator. Data will be shared via institutional email upon approval.
De-identified individual participant data (IPD) related to primary and secondary outcomes will be shared upon reasonable request. Data will be available after publication and can be requested by contacting the principal investigator.